Sort
82,697 grants matching “vaccine development”
Molecular Genetics Of Eukaryotic Cells And Their Viruses
$2,872,207Malcolm Martin · Niaid Extramural Activities · Z01 · FY2007 · AI
Pitt RBL
$2,870,240William Paul Duprex · University Of Pittsburgh At Pittsburgh · UC7 · FY2023 · AI
Disrupted Adenovirus Serotype 5-based Anti-cocaine Vaccine
$2,868,677Ronald G Crystal · Weill Medical Coll Of Cornell Univ · U01 · FY2012 · DA
Clinical Trials of Biodefense Vaccines (Dengue, West Nile Virus, TBEV)
$2,868,147Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS): UNIVERSAL INFLUENZA RESEARCH EFFORTS
$2,865,600Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · N01 · FY2018 · AI
UZ-UCSF CTU
$2,864,034Zvavahera Mike Chirenje · University Of California, San Francisco · UM1 · FY2025 · AI
Immunologic and virologic determinants of congenital Cytomegalovirus transmission and disease in rhesus monkeys
$2,863,852Sallie R. Permar · Duke University · P01 · FY2019 · AI
Discovery of New Innate Immune Pathways in Viral Recognition
$2,863,677Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · U19 · FY2015 · AI
Discovery of New Innate Immune Pathways in Viral Recognition
$2,863,677Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · U19 · FY2017 · AI
Mechanisms of CD4 T cell help to myeloid cells in tuberculosis
$2,863,501Tyler Dallas Bold · University Of Minnesota · R01 · FY2025 · AI
UAB-MISS MACS/WIHS Combined Cohort Study
$2,863,446Mirjam-Colette Kempf · University Of Alabama At Birmingham · U01 · FY2020 · HL
Enhancing Chimeric Antigen Receptor T Cell Therapies for HematologicMalignancies: Beyond CART 19
$2,863,199Carl H. June · University Of Pennsylvania · P01 · FY2025 · CA
HIV-1 Vaccine Based on Chimp Serotypes of Adenovirus
$2,861,413Hildegund C. J. Ertl · Wistar Institute · U19 · FY2008 · AI
Structure and Immunogenicity of Cleaved, Stabilized HIV-1 Envelope Trimers
$2,860,535William C Olson · Progenics Pharmaceuticals, Inc. · P01 · FY2009 · AI
CCR Genomics Core
$2,859,914Elizabeth Conner · Division Of Basic Sciences - Nci · ZIC · FY2023 · CA
Spore in Head and Neck Cancer
$2,858,317David Sidransky · Johns Hopkins University · P50 · FY2013 · DE
UAB-MISS MACS/WIHS Combined Cohort Study
$2,857,804Mirjam-Colette Kempf · University Of Alabama At Birmingham · U01 · FY2024 · HL
Bone Marrow Transplantation in Human Disease
$2,857,642Richard J Jones · Johns Hopkins University · P01 · FY2007 · CA
Virus-Host Interactions: Induction and Evasion of Host Innate Immunity
$2,856,391Sonja Best · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
SPORE IN BREAST CANCER
$2,855,986Johns Hopkins University · P50 · FY2003 · CA
Durban International Clinical Trials Unit
$2,855,468Umesh G Lalloo · University Of Kwazulu-Natal · U01 · FY2009 · AI
Advanced Development and Clinical Evaluation of an Entamoeba histolytica Vaccine
$2,853,145Christopher Fox · Access To Advanced Health Institute · N01 · FY2021 · AI
NIAID Microbiome Program
$2,850,841Yasmine Belkaid · National Institute Of Allergy And Infectious Diseases · ZIC · FY2019 · AI
Defining signatures for immune responsiveness by functional systems immunology
$2,849,006David A. Hafler · Yale University · U19 · FY2011 · AI
Integrating innate and adaptive pathways in vaccine responses
$2,848,678Jeffrey Victor Ravetch · Rockefeller University · U19 · FY2018 · AI